Salix Pharmaceuticals, Ltd. - Strategy, SWOT and Corporate Finance Report

January 2017 | 46 pages | ID: SBA3F39CDEFEN
MarketLine

Abstracts

SUMMARY

Salix Pharmaceuticals, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

KEY FINDINGS

• Detailed information on Salix Pharmaceuticals, Ltd. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Salix Pharmaceuticals, Ltd. in the form of a SWOT analysis
• An in-depth view of the business model of Salix Pharmaceuticals, Ltd. including a breakdown and examination of key business segments
• Intelligence on Salix Pharmaceuticals, Ltd.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Salix Pharmaceuticals, Ltd., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

REASONS TO BUY

• Gain understanding of Salix Pharmaceuticals, Ltd. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Salix Pharmaceuticals, Ltd. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Salix Pharmaceuticals, Ltd.'s business structure, strategy and prospects.

KEY HIGHLIGHTS

Salix Pharmaceuticals (Salix or 'the company') is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of prescription pharmaceutical products for the treatment of gastrointestinal diseases. The company's marketed drugs include Xifaxan, Osmoprep and Metozolv ODT. Salix primarily operates in the US, where it is headquartered in Raleigh, North Carolina. It employed about 1,000 people as of December 31, 2014.

Contents

Company Snapshot
  Salix Pharmaceuticals, Ltd.: Company Overview
  Salix Pharmaceuticals, Ltd.: Overview and Key Facts
    Salix Pharmaceuticals, Ltd.: Overview
    Salix Pharmaceuticals, Ltd.: Key Facts
  Salix Pharmaceuticals, Ltd.: Key Employees
  Salix Pharmaceuticals, Ltd.: Key Employee Biographies
  Salix Pharmaceuticals, Ltd.: Major Products and Services
  Salix Pharmaceuticals, Ltd.: Company History
  Salix Pharmaceuticals, Ltd.: Management Statement
  Salix Pharmaceuticals, Ltd.: Locations and Subsidiaries
  Salix Pharmaceuticals, Ltd.: Key Competitors
Salix Pharmaceuticals, Ltd.: Company Analysis
  Salix Pharmaceuticals, Ltd.: Business Description
  Salix Pharmaceuticals, Ltd.: SWOT Analysis
    Salix Pharmaceuticals, Ltd.: SWOT Overview
    Salix Pharmaceuticals, Ltd.: Strengths
    Salix Pharmaceuticals, Ltd.: Weaknesses
    Salix Pharmaceuticals, Ltd.: Opportunities
    Salix Pharmaceuticals, Ltd.: Threats
  Salix Pharmaceuticals, Ltd.: Corporate Financial Deals Activity
  Salix Pharmaceuticals, Ltd.: Financial Deals Overview
  Salix Pharmaceuticals, Ltd.: Targets and Partners
  Salix Pharmaceuticals, Ltd.: Top Deals 2013 - 2017YTD
  Salix Pharmaceuticals, Ltd.: Advisors
    Salix Pharmaceuticals, Ltd.: Top Financial Advisors
  Salix Pharmaceuticals, Ltd.: Mergers and Acquisitions
  Salix Pharmaceuticals, Ltd.: Partnership
  Salix Pharmaceuticals, Ltd.: Private Equity and Ownership
Salix Pharmaceuticals, Ltd.: Recent Developments
  Salix Pharmaceuticals, Ltd.: News and Events Summary
  Salix Pharmaceuticals, Ltd.: Business Expansion
  Salix Pharmaceuticals, Ltd.: Business Reorganization
  Salix Pharmaceuticals, Ltd.: Corporate Governance
  Salix Pharmaceuticals, Ltd.: Financial Deals
  Salix Pharmaceuticals, Ltd.: Financial Performance
  Salix Pharmaceuticals, Ltd.: Red Flags/Distress Signals
  Salix Pharmaceuticals, Ltd.: Red Flags/DistressSignals
  Salix Pharmaceuticals, Ltd.: Regulatory and Legal Events
  Salix Pharmaceuticals, Ltd.: Research and Development
Appendix
  Contact Us
  Methodology
  Definitions
  About Datamonitor

List Of Tables

LIST OF TABLES

Table 1: Salix Pharmaceuticals, Ltd.: Key Facts
Table 2: Salix Pharmaceuticals, Ltd.: Key Employees
Table 4: Salix Pharmaceuticals, Ltd.: Key Competitors
Table 5: Salix Pharmaceuticals, Ltd.: Deal Activity by Deal Type - Volume (2013 - YTD2017)
Table 6: Salix Pharmaceuticals, Ltd.: MandA Average Deal Size - Value (US$m)
Table 7: Salix Pharmaceuticals, Ltd.: Targets and Partners
Table 8: Salix Pharmaceuticals, Ltd.: Top Deals 2013 - 2017YTD
Table 9: Salix Pharmaceuticals, Ltd.: Financial Advisor Ranking by Value (US$m)
Table 10: Salix Pharmaceuticals, Ltd.: MandA Volume and Value Trend (2013 - YTD2017)
Table 11: Salix Pharmaceuticals, Ltd.: MandA Activity by Geography (2013 - YTD2017)
Table 12: Salix Pharmaceuticals, Ltd.: Partnership Volume and Value Trend (2013 - YTD2017)
Table 13: Salix Pharmaceuticals, Ltd.: Partnership Trend by Deal Type (2013 - YTD2017)
Table 14: Salix Pharmaceuticals, Ltd.: Private Equity and Ownership Volume and Value Trend (2013 - YTD2017)
Table 15: Salix Pharmaceuticals, Ltd.: Private Equity and Ownership Volume by Deal Type (2013 - YTD2017)
Table 16: Salix Pharmaceuticals, Ltd.: News and Events Summary
Table 17: Salix Pharmaceuticals, Ltd.: Business Expansion
Table 18: Salix Pharmaceuticals, Ltd.: Business Reorganization
Table 19: Salix Pharmaceuticals, Ltd.: Corporate Governance
Table 20: Salix Pharmaceuticals, Ltd.: Financial Deals
Table 21: Salix Pharmaceuticals, Ltd.: Financial Performance
Table 22: Salix Pharmaceuticals, Ltd.: Red Flags/Distress Signals
Table 23: Salix Pharmaceuticals, Ltd.: Red Flags/DistressSignals
Table 24: Salix Pharmaceuticals, Ltd.: Regulatory and Legal Events
Table 25: Salix Pharmaceuticals, Ltd.: Research and Development

List Of Figures

LIST OF FIGURES

Figure 1: Salix Pharmaceuticals, Ltd.: Deal Activity by Deal Type - Volume (2013 - YTD2017)
Figure 2: Salix Pharmaceuticals, Ltd.: MandA Average Deal Size - Value (US$m)
Figure 3: Salix Pharmaceuticals, Ltd.: MandA Volume and Value Trend (2013 - YTD2017)
Figure 4: Salix Pharmaceuticals, Ltd.: MandA Activity by Geography (2013 - YTD2017)
Figure 5: Salix Pharmaceuticals, Ltd.: Partnership Volume and Value Trend (2013 - YTD2017)
Figure 6: Salix Pharmaceuticals, Ltd.: Partnership Trend by Deal Type (2013 - YTD2017)
Figure 7: Salix Pharmaceuticals, Ltd.: Private Equity and Ownership Volume and Value Trend (2013 - YTD2017)
Figure 8: Salix Pharmaceuticals, Ltd.: Private Equity and Ownership Volume by Deal Type (2013 - YTD2017)

COMPANIES MENTIONED

Salix Pharmaceuticals, Ltd.